GSK plc (NYSE: GSK) is scheduled to reveal its financial results for the third quarter on Wednesday 30th October 2024. This disclosure will take place before market open, providing investors with significant information regarding the company's performance in the last three months period.
Wall Street financial experts forecast that the business is set to announce an expected $1.23 profit per share for the quarter. Moreover, the company is anticipated to disclose a total revenue of $10.78 billion for this particular period.
Upon revisiting the corresponding quarter from the prior year, the company's earnings report demonstrated a per-share income of $1.27. This figure was attributed to the company's total revenue, which reached an impressive $10.27 billion during that same period.
Wall Street analysts have unveiled their forecasts for the company's yearly performance, estimating a total revenue of $41.46 billion. Additionally, they expect the company to reach profit of $4.06 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.10 | +13.4% | 9.95 B | +10.9% |
| Q1 2024 | $1.09 | +21.1% | 9.34 B | +10.6% |
| Q4 2023 | $0.72 | +18.0% | 10.07 B | +16.3% |
| Q3 2023 | $1.27 | +14.4% | 10.27 B | +11.1% |
| Q2 2023 | $0.97 | +11.5% | 8.97 B | +2.9% |
| *Growth on year-over-year basis | ||||
GSK plc (GSK) closed Monday's regular trading session at $37.88, indicating a 0.96 percent gain. During the day, GSK shares traded between $37.67 and $38.09, with a day volume of 4.11 million shares.
